4//SEC Filing
Buell Jennifer 4
Accession 0001193125-25-201376
CIK 0001840229other
Filed
Sep 10, 8:00 PM ET
Accepted
Sep 11, 4:46 PM ET
Size
7.5 KB
Accession
0001193125-25-201376
Insider Transaction Report
Form 4
Buell Jennifer
Chief Executive Officer
Transactions
- Award
Common Stock
2025-09-09$15.36/sh+18,229$279,997→ 41,913 total - Award
Stock Option (Right to Buy)
2025-09-09+50,000→ 50,000 totalExercise: $15.36Exp: 2035-09-09→ Common Stock (50,000 underlying)
Footnotes (3)
- [F1]Reflects the executive's 2024 performance bonus award paid in MiNK Therapeutics, Inc. common stock. The stock issued is fully-vested on the date of issuance but is subject to a lockup restriction with 100% of the award released on October 9, 2025.
- [F2]$15.36 was the fair market value of MiNK Therapeutics, Inc. Common Stock on September 9, 2025, the stock issuance date.
- [F3]The option vests over a three-year period, with one-third of the options vesting on the one-year anniversary of the date of grant, with the remainder vesting in eight equal quarterly installments thereafter, provided that the Reporting Person continues to serve on the Issuer's Board of Directors through such date.
Documents
Issuer
MiNK Therapeutics, Inc.
CIK 0001840229
Entity typeother
Related Parties
1- filerCIK 0001711184
Filing Metadata
- Form type
- 4
- Filed
- Sep 10, 8:00 PM ET
- Accepted
- Sep 11, 4:46 PM ET
- Size
- 7.5 KB